The Pennant Group, Inc. PNTG
As ofNov 17, 2026, 1:21 PM EST
- YTD
- +31.24%
- 1 year
- +45.45%
- Market cap
- 1.30B
- Revenue (ttm)
- 1.17B
- Profit margin
- 3.05%
- EPS (ttm)
- 1.01
- Shares out
- 35.13M
- P/E ratio
- 36.52
- Forward P/E
- 23.42
- YTD return
- +31.24%
- 1-year return
- +45.45%
- 50-day average
- 40.04
- Volume
- 148.08K
- Avg volume
- 375.10K
- Open
- 36.97
- Previous close
- 37.03
- Day's range
- 36.55 – 38.28
- 52-week range
- 25.57 – 44.24
- Beta
- 1.30
- Analysts
- Strong Buy
- Price target
- 48.00 (+29.9%)
- Earnings date
- Feb 24, 2027
5D +0.85 (+2.35%)
Key statistics
- 200-day average
- 35.89
- Enterprise value
- 1.78B
- PEG ratio
- 1.76
- Price / sales
- 1.11
- Price / book
- 3.48
- Revenue growth
- 32.00%
- Free cash flow
- -8.02M
- Total cash
- 18.39M
- Total debt
- 488.93M
- Return on equity
- 11.18%
- Short % of float
- 3.51%
Fundamental scorecard
12 of 25 checks passed on PNTG’s reported financials
12of 25 checks passed
- Value 1 of 5
- Growth 5 of 5
- Profitability 4 of 5
- Financial health 2 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Analyst view
Consensus: strong buy
- Target (low)
- 46.00
- Target (mean)
- 48.00
- Target (high)
- 50.00
- Strong buy1
- Buy6
- Hold0
- Sell0
- Strong sell0
Next earnings
Feb 24, 2027
Expected Feb 24, 2027. Consensus EPS estimate 0.36167.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 24, 2027 | Dec 30, 2026 | 0.35 | — | — | — |
| Nov 4, 2026 | Sep 30, 2026 | 0.3574 | 0.35 | -0.01 | -2.07% |
| Aug 5, 2026 | Jun 30, 2026 | 0.3316 | 0.36 | +0.03 | +8.56% |
| May 6, 2026 | Mar 31, 2026 | 0.31 | 0.32 | +0.01 | +3.23% |
| Feb 25, 2026 | Dec 31, 2025 | 0.31 | 0.34 | +0.03 | +9.68% |
| Nov 5, 2025 | Sep 30, 2025 | 0.29 | 0.30 | +0.01 | +3.45% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 6, 2026 | RBC Capital | main | Outperform | Outperform |
| Nov 5, 2026 | Oppenheimer | main | Outperform | Outperform |
| Aug 20, 2026 | RBC Capital | main | Outperform | Outperform |
| Aug 11, 2026 | Wells Fargo | main | Overweight | Overweight |
| Jul 14, 2026 | Truist Securities | main | Buy | Buy |
| Jul 13, 2026 | Wells Fargo | main | Overweight | Overweight |
About The Pennant Group, Inc.
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities in Alabama, Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Tennessee, Texas, Utah, Washington, Wisconsin, and Wyoming. The Company was incorporated in 2019 and is headquartered in Eagle, Idaho.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- pennantgroup.com
News
Pennant Group to Participate in the 2026 Stephens Annual Investment Conference RBC Capital Maintains Outperform on Pennant Gr, Raises Price Target to $48
Conference call: Pennant Gr Affirms FY2026 Adj EPS Guidance of $1.34-$1.41 vs $1.40 Est; Affirms FY2026 Sales Guidance of $1.171B-$1.190B vs $1.184B Est
Pennant Gr Q3 2026 Earnings Call Transcript Oppenheimer Maintains Outperform on Pennant Gr, Raises Price Target to $50
Your note
Sign in to keep a note on PNTG — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHRISTENSEN CHRISTOPHER R | Director | Stock Award(Grant) | Oct 14, 2026 | 771,238 |
| COVEY STEPHEN M.R. | Director | Stock Award(Grant) | Oct 14, 2026 | 45,950 |
| GOCHNOUR JOHN J | Chief Operating Officer | Conversion of Exercise of derivative security | Oct 22, 2026 | 144,788 |
| GUERISOLI BRENT | Chief Executive Officer | Sale | Aug 5, 2026 | 99,544 |
| LAMB SCOTT E | Director | Stock Award(Grant) | Oct 14, 2026 | 61,335 |
| MORRIS GREGORY K. SR. | Director | Stock Award(Grant) | Oct 14, 2026 | 39,200 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 8.41% | 2,955,781 | 109.45M | Sep 29, 2026 |
| Van Berkom & Associates Inc. | 6.16% | 2,165,636 | 80.19M | Sep 29, 2026 |
| Wasatch Advisors LP | 5.13% | 1,801,112 | 66.70M | Sep 29, 2026 |
| Turtle Creek Asset Management Inc. | 4.81% | 1,688,586 | 62.53M | Sep 29, 2026 |
| Vanguard Capital Management LLC | 4.20% | 1,476,105 | 54.66M | Sep 29, 2026 |
| Paradigm Capital Management | 3.80% | 1,334,800 | 49.43M | Sep 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.99% | 1,049,539 | 38.86M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.50% | 878,859 | 32.54M | Sep 29, 2026 |
| Columbia Acorn Trust-Columbia Acorn Fund | 1.99% | 699,307 | 25.90M | Jun 29, 2026 |
| WASATCH FUNDS TRUST-Wasatch Small Cap Growth Fund | 1.91% | 672,197 | 24.89M | Sep 29, 2026 |
| First Eagle Funds-First Eagle Small Cap Opportunity Fund | 1.47% | 517,208 | 19.15M | Jul 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.13% | 396,035 | 14.67M | Jun 29, 2026 |
